CCL5 and cancer: In a conclusion, our results indicated that effective dose of palbociclib could arrest the cell cycle and induce apoptosis of cancer cells; however, palbociclib might induce cell senescence and enhance migration and invasion of cancer cells via SASP-related autocrine CCL5 (Figure 7(b)).